Self-Medication Practice among Amman’s Householders: Prevalence and Factors
|
Author |
Salah A. Al Shehade, Derar H. Abdel-Qader, Raghdaa H. Al Zarzour, Abdul Razzak Alshehadeh and Salim Hamadi |
|
Published in |
Journal of Pharmaceutical Research International, volume 32, issue 11, page 102-113, 2020. |
COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties
|
Author |
Muhammad Asif, Mohammad Saleem, Malik Saadullah, Hafiza Sidra Yaseen and Raghdaa Al Zarzour |
|
Published in |
Inflammopharmacology, volume 28, pages1153–1161, 2020. |
The dual impact of Jordanian Ephedra alte for inhibiting pepsin and treating microbial infections
|
Author |
Haya Ayyal Salman, Amira Suriaty Yaakop, Ahmed Al-Mustafa, Khaled Tarawneh, Saleem Aladaileh, Fuad Al-Rimawi, Fadi Alakhras, Saleh Abu-Lafi, Raghdaa Al Zarzour and Habibah Wahab |
|
Published in |
Saudi Journal of Biological Sciences, volume 28, issue 11, Pages 6245-6253, November 2021. |
A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet
|
Author |
Mohammed Abdullah Alshawsh, Abdulsamad Alsalahi, Salah Abdalrazak Alshehade, Sultan Ayesh Mohammed Saghir, Ahmad Faheem Ahmeda, Raghdaa Hamdan Al Zarzour, Ayman Moawad Mahmoud |
|
Published in |
Molecules, 27 (3), 858, (This article belongs to the Special Issue: Animal Models of Human Diseases and Their Potential Therapies of Natural Products or Pure Components), 2022. |
Anticlastogenic, antimutagenic, and cytoprotective properties of Orthosiphon stamineus ethanolic leaves extract
|
Author |
Dhamraa W Al-Dulaimi, Aman Shah Abdul Majid, Hussein M. Baharetha, Mohamed B Khadeer Ahamed, Sarah Furqan Faisal, Raghdaa Hamdan Al Zarzour, Chern Ein Oon, Amin Malik Shah Abdul Majid and Loiy E Ahmed Hassan |
|
Published in |
Drug and Chemical Toxicology, volume 45, issue 2, 2022. |
Mechanism of action of Orthosiphon stamineus against non-alcoholic fatty liver disease: Insights from systems pharmacology and molecular docking approaches
|
Researchers |
Salah Abdulrazak Alshehade, Raghdaa Hamdan Al Zarzour, Vikneswaran Murugaiyah, Sharoen Yu Ming Lim, Huda Ghaleb El-Refae, Mohammed Abdullah Alshawsh |
|
Published in |
Saudi Pharmaceutical Journal, volume 30, issue 11, Pages 1572-1588, November 2022. |
Mechanism of action of Orthosiphon stamineus against non-alcoholic fatty liver disease: Insights from systems pharmacology and molecular docking approaches
|
Researchers |
Salah Abdulrazak Alshehade, Raghdaa Hamdan Al Zarzour, Vikneswaran Murugaiyah, Sharoen Yu Ming Lim, Huda Ghaleb El-Refae, Mohammed Abdullah Alshawsh |
|
Published in |
Saudi Pharmaceutical Journal, volume 30, issue 11, Pages 1572-1588, November 2022. |
Syrian females with congenital adrenal hyperplasia: a case series
|
Researchers |
Nada Dehneh, Rami Jarjour, Sahar Idelbi, Assad Alibrahem and Sahar Al Fahoum |
|
Published in |
Journal of Medical Case Reports, volume 16, article number: 371, October 2022. |
Syrian females with congenital adrenal hyperplasia: a case series
|
Researchers |
Nada Dehneh, Rami Jarjour, Sahar Idelbi, Assad Alibrahem and Sahar Al Fahoum |
|
Published in |
Journal of Medical Case Reports, volume 16, article number: 371, October 2022. |
Medicinal plants’ proposed nanocomposites for the management of endocrine disorders
|
Researchers |
Raghdaa Hamdan Al Zarzour, Ezatul Ezleen Kamarulzaman, Fadi G. Saqallah, Fauziahanim Zakaria, Muhammad Asif, Khairul Niza Abdul Razak |
|
Published in |
Heliyon, volume 8, issue 9, part of the “Ethnopharmacology – challenges for the future” Special issue, article number 10665, September 2022. |
Medicinal plants’ proposed nanocomposites for the management of endocrine disorders
|
Researchers |
Raghdaa Hamdan Al Zarzour, Ezatul Ezleen Kamarulzaman, Fadi G. Saqallah, Fauziahanim Zakaria, Muhammad Asif, Khairul Niza Abdul Razak |
|
Published in |
Heliyon, volume 8, issue 9, part of the “Ethnopharmacology – challenges for the future” Special issue, article number 10665, September 2022. |
The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: New insights and future directions
|
Researchers |
Salah Alshehade, Mohammed Abdullah Alshawsh, Vikneswaran Murugaiyah, Muhammad Asif, Omayma Alshehade, Hassan Almoustafa, Raghdaa Al Zarzour |
|
Published in |
Life Sciences, volume 305, article 120732, September 2022. |